|
WO2020231943A1
|
|
Modifications of mammalian cells using artificial micro-rna to alter their properties and the compositions of their products
|
|
US2020318107A1
|
|
Transposition of nucleic acids into eukaryotic genomes with a transposase from heliothis
|
|
US2020318121A1
|
|
Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias
|
|
WO2020210237A1
|
|
Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois
|
|
WO2020163755A1
|
|
Transposon-based modifications of immune cells
|
|
US2020283798A1
|
|
Dna vectors and elements for sustained gene expression in eukaryotic cells
|
|
US2015225468A1
|
|
Fluorescent and colored proteins and methods for using them
|
|
US2014329233A1
|
|
Methods, compositions and kits for a one-step DNA cloning system
|
|
US2014178914A1
|
|
Fluorescent and colored proteins and methods for using them
|
|
EP2427559A2
|
|
Biotransformation using genetically modified candida
|
|
EP2294407A2
|
|
Systems and methods for determining properties that affect an expression property value of polynucleotides in an expression system
|
|
US7561973B1
|
|
Methods for determining properties that affect an expression property value of polynucleotides in an expression system
|
|
US7561972B1
|
|
Synthetic nucleic acids for expression of encoded proteins
|
|
WO2009017673A2
|
|
Methods, compositions, and kits for one-step dna cloning using dna topoisomerase
|
|
US2007043516A1
|
|
Systems and methods for designing and ordering polynucleotides
|
|
EP1939779A2
|
|
Systems and methods for biopolymer engineering
|
|
WO2005012877A2
|
|
Systems and methods for antibody engineering
|
|
US2006136184A1
|
|
Systems and methods for biopolymer engineering
|
